5 Most Undervalued Large-Cap Stocks To Buy According To Analysts

Page 1 of 5

In this article, we will be taking a look at the 5 most undervalued large-cap stocks to buy according to analysts. To read our detailed analysis of current stock market dynamics, you can go directly to see the 16 Most Undervalued Large-Cap Stocks To Buy According To Analysts.

5. Novartis AG (NYSE:NVS)

Number of Hedge Fund Holders: 28

Average Analyst Price Target: $111.5

Market Capitalization: $209.1 billion

Upside Potential: 16.7%

Novartis AG (NYSE:NVS) is a pharmaceutical company based in Switzerland. It develops healthcare products and offers prescription medicines, among more.

BMO Capital analysts initiated coverage on Novartis AG (NYSE:NVS) with a Market Perform rating and a $114 price target on February 23.

We saw 28 hedge funds long Novartis AG (NYSE:NVS) in the fourth quarter, with a total stake value of $874.9 million.

Follow Novartis A G (NYSE:NVS)

Page 1 of 5